ASH 2018: Phoenix and other DLBCL study updates

Professor Anas Younes (New York, USA) and Dr Andrew Davies (Southampton, UK) discuss the outcomes from the Pheonix study, with Professor Anas Younes (New York, USA) highlighting future plans following this study

By Tom Collins (article) and Esther Drain (interview)

Professor John Radford (Manchester, UK) reviews the data coming from the FIH trial of Adct-402 for R/R DLBCL